Patient Questions on the COVID-19 Vaccine: Nurses Weigh In
We spoke with a group of oncology nurses about the questions that patients are asking regarding the COVID-19 vaccine.
We spoke with a group of oncology nurses about the questions that patients are asking regarding the COVID-19 vaccine.
A subgroup of patients from the 3 CARTITUDE trials experienced cranial nerve palsy after treatment, most of whom were men.
As symptom severity can vary by patient, it is key for nurses to increase assessment for early intervention of patients with head and neck cancer…
Establishing a nurse-led system to administer tocilizumab in patients receiving bispecific antibodies tended to get the immunosuppressive drug to patients faster.
A feasibility study on the use of a mobile application for patients after undergoing a stem cell transplant may help care teams quickly identify and…
Patients who were given telehealth, vs in-person, exercise programs to manage their symptoms from cancer care experienced similar outcomes, highlighting an alternative for providers to…
Results from the CARTITUDE-2 trial support cilta-cel in patients with multiple myeloma, which addresses the unmet needs of these patients, an expert presented.
An oncology nurse details strategies used at his institution to reduce burnout — which can ultimately decrease the rate of “silent quitting.”
Encouraging responses were observed in most patients with relapsed/refractory follicular lymphoma treated with loncastuximab tesirine and rituximab.
Patients in the CARTITUDE-4 trial experienced a high response rate to the treatment as early as their first relapse.
The establishment of a multidisciplinary committee can help identify opportunities to best face the ongoing cancer drug shortage.